Shire Backs Hemophilia Focus With Asset Updates, Irish iPATH Study

Newly enlarged Shire PLC is showcasing its Baxalta component's dynamic hematology portfolio and pipeline at the WFH congress in Orlando, Florida and tells Scrip of its plans for a novel study in Ireland with renowned institutions there using advanced data technology to redefine hemophilia care.

SC1607_Valentino_quote_1200x675

More from Clinical Trials

More from R&D